Get it on Google Play

Amylyx to release Phase 3 avexitide trial results Aug. 18

August 17, 2026 4:01 PM EDT Send to a Friend
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) is set to release topline results from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login